MedTrace Logo

International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

NCT05096091 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5399

Last updated 2025-12-18

No results posted yet for this study

Summary

InVITE is funded by NIAID and is conducted in multiple international sites (approximately 20 sites across 7 countries).

This is a study of adults who receive locally available COVID-19 vaccines through local vaccination programs. Persons will be enrolled within one day (before or after) of receipt of a COVID-19 vaccine. The study will enroll participants who receive COVID-19 vaccination at local clinics and/or study sites.

Conditions

Sponsors & Collaborators

  • Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

    collaborator OTHER

  • Partnership for Clinical Research in Guinea/Partenariat de Recherche Clinique en Guinée (PREGUI)

    collaborator UNKNOWN

  • Partnership for Research on Ebola Virus in Liberia (PREVAIL)

    collaborator NETWORK

  • University Clinical Research Center, Mali

    collaborator OTHER

  • Onom Foundation and Liver Center

    collaborator UNKNOWN

  • Mexican Emerging Infectious Diseases Clinical Research Network

    collaborator NETWORK

  • Ina-Respond

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Renee Ridzon, MD · National Institute of Allergy and Infectious Diseases (NIAID)

  • Irini Sereti, MD · National Institute of Allergy and Infectious Diseases (NIAID)

  • Sally Hunsberger, PhD · National Institute of Allergy and Infectious Diseases (NIAID)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-16
Primary Completion
2025-08-19
Completion
2025-08-19

Countries

  • Democratic Republic of the Congo
  • Guinea
  • Indonesia
  • Liberia
  • Mali
  • Mexico
  • Mongolia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05096091 on ClinicalTrials.gov